A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

Condition:   Peripheral T Cell Lymphoma Interventions:   Drug: Bortezomib;   Drug: Etoposide;   Drug: Cyclophosphamide;   Drug: Pharmorubicin;   Drug: Prednisone Sponsor:   Zhejiang Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials